Draupnir Bio • News

Showing

News

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins

News

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins

18 July 2024

5 min

Our CSO Simon Glerup is invited speaker at the 4th Annual TPD Europe conference, presenting our platform for small molecule degraders of extracellular proteins

Event

Our CSO Simon Glerup is invited speaker at the 4th Annual TPD Europe conference, presenting our platform for small molecule degraders of extracellular proteins

19 March 2024

Event

Our Chief Scientific Officer Simon Glerup will present our small molecule platform for targeted degradation of extracellular proteins at the 1st Annual Targeted Protein Degradation for CNS Summit.

November 2023

News

Draupnir Bio establishes Scientific Advisory Board of international experts in cholesterol metabolism and cardiovascular disease

September 2021

4 min

Draupnir Bio expands research operations with new facility at INCUBA research park

News

Draupnir Bio expands research operations with new facility at INCUBA research park

August 2021

2 minutes read

Andrew Hotchkiss joins Draupnir Bio as CEO

News

Andrew Hotchkiss joins Draupnir Bio as Chief Executive Officer

June 2021

3 min

News

Draupnir Bio secures Euro 30 million in Series A funding round

October 2019

2 min